Aptar Pharma to showcase an industry first

12 Sep 2018

PureHale is a new portable drug delivery device designed for upper respiratory care.

Aptar Pharma will showcase an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care - at CPhI Worldwide this year in Madrid.

Aptar Pharma to showcase an industry first

In addition to PureHale, Aptar Pharma will also reveal:

  • A range of new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes
  • A portfolio of gamma-sterilized drug delivery components to reduce bioburden
  • Aptar Pharma’s Support Services initiative, a portfolio of stage-specific development packages to help customers in their journey from molecule to market.
  • “Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI, and working with our customers to meet their development needs, said Guillaume Brouet, Vice President Analytical, Regulatory and Scientific Affairs at Aptar Pharma.”

    Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.

    Furthermore, Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:

    “Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”

    Julie D. Suman, President of Next Breath, a division of Aptar Pharma, Tuesday 9 October, 11:50-12:20.

    Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.

    “Portable care for your respiratory tract: Exploring new technology platforms”

    Guenter Nadler, Director Business Development, Aptar Pharma, Tuesday 9 October, 12:30-13:00

    Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally, including new respiratory technology platforms that will meet new market needs.

    “Building a connected devices eco-system for digital medicines”

    Sai Shankar, Director Business Development, Aptar Pharma Wednesday 10 October, 13:50-14:20.

    Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimised through patient-centric design, secure data collection and management, and cross-platform interoperability.

    Read More

    Related news

    FDA approves first generic version of Sabril tablets

    FDA approves first generic version of Sabril tablets

    17 Jan 2019

    Approval of generic vigabatrin tablets granted to Teva Pharmaceuticals USA.

    Read more 
    New software platform improves freeze drying process control

    New software platform improves freeze drying process control

    16 Jan 2019

    The LyoS 2.0 control system software is fully configurable and fully validatable for regulated pharmaceutical and biotechnology applications.

    Read more 
    Preparing samples of cannabis plant for THC/CBD analysis

    Preparing samples of cannabis plant for THC/CBD analysis

    15 Jan 2019

    Porvair Sciences has created a solid, stable and strong microplate that can withstand the applied forces in bead-beaters while maintaining a standard ANSI/SLAS footprint and key dimensions.

    Read more 
    BASF’s new active ingredients target skin conditions’ root causes

    BASF’s new active ingredients target skin conditions’ root causes

    15 Jan 2019

    New active ingredients coming from the research of BASF’s innovation platforms on epigenetics, microbiome and extraction.

    Read more 
    MedPharm expands to de-risk customers' development programs

    MedPharm expands to de-risk customers' development programs

    14 Jan 2019

    The $4-million investment will be used to expand topical dosage formulation development services and innovative performance testing on topical and transdermal pharmaceutical products.

    Read more 
    Univercells introduces breakthrough vaccine manufacturing platform

    Univercells introduces breakthrough vaccine manufacturing platform

    13 Jan 2019

    The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint.

    Read more 
    Allergan to establish R&D presence in Cambridge, Massachusetts

    Allergan to establish R&D presence in Cambridge, Massachusetts

    10 Jan 2019

    The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area.

    Read more 
    Expedeon signs supply and license agreement for is Lightning-Link technology

    Expedeon signs supply and license agreement for is Lightning-Link technology

    9 Jan 2019

    The technology will enable Cell Guidance Systems to manufacture TRIFic detection assays on-demand with highly reproducible and scalable results.

    Read more 
    Lilly to bag Loxo Oncology for $8 billion

    Lilly to bag Loxo Oncology for $8 billion

    8 Jan 2019

    Acquisition will broaden the scope of Lilly's oncology portfolio into precision medicines.

    Read more 
    Catalent to double its commercial biomanufacturing capacity

    Catalent to double its commercial biomanufacturing capacity

    7 Jan 2019

    The $200-million expansion will support customers’ development programs and commercial launches.

    Read more